Subject
Cardiology and Cardiovascular Medicine,Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)
Reference67 articles.
1. Guidance for industry diabetes mellitus — evaluating cardio vascular risk in new antidiabetic therapies to treat type 2 diabetes;U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER),2008
2. Oral hypoglycemic agents and the heart failure conundrum: lessons from and for outcome trials;Kappel;Nutr Metab Cardiovasc Dis,2015
3. Novel antidiabetic drugs and CR: primum non nocere;Bonadonna;Nutr Metab Cardiovasc Dis,2016
4. Current cardiovascular outcomes trials in type 2 diabetes: perspectives and insight;Coch;Nutr Metab Cardiovasc Dis,2016
5. EMPA-REG OUTCOME Investigators. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes;Zinman;N Engl J Med,2015
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献